US Broker Ratings

Roivant Sciences Ltd. (ROIV): Analyst Consensus Signals a Promising 43.55% Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company headquartered in London, is capturing investor attention with a compelling potential upside of 43.55%. Despite facing challenges..

Bio-Techne Corp (TECH) Stock Analysis: Promising 14.39% Upside Amidst Strong Analyst Support

Bio-Techne Corporation (NASDAQ: TECH), a leader in the biotechnology sector, is garnering significant attention from investors thanks to its robust market position and promising growth potential...

Charles River Laboratories (CRL) Investor Outlook: Navigating Growth with a 6.32% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a compelling player in the healthcare sector, specifically within the diagnostics and research industry. Based in Wilmington,..

Universal Health Services, Inc. (UHS) Stock Analysis: Potential 17.64% Upside and Robust Revenue Growth Attract Investors

Universal Health Services, Inc. (NYSE: UHS), a key player in the healthcare sector, has been making waves with its strong financial metrics and promising growth potential...

Chemed Corp (CHE) Stock Analysis: Healthcare Leader Offers 23.57% Potential Upside

Chemed Corp (NYSE: CHE) stands out as a key player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 29.84% Potential Upside in the Biotech Sector

Ascendis Pharma A/S (NASDAQ: ASND), headquartered in Hellerup, Denmark, continues to captivate investors in the healthcare sector with its promising pipeline and robust revenue growth. Specializing..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 14.93% Potential Upside

Investors with a keen eye on the healthcare sector should give serious consideration to Merck & Company, Inc. (NYSE: MRK), a titan in the drug manufacturing..

The Ensign Group, Inc. (ENSG) Stock Analysis: Robust Revenue Growth and Strategic Expansion Signal Promising Prospects

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: A 23.99% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a major player in the healthcare sector, stands out with its robust market presence and promising growth potential. Specializing in..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating Growth with a 6.99% Upside Potential

In the dynamic world of medical devices, Edwards Lifesciences Corporation (NYSE: EW) emerges as a significant player, focusing on innovative cardiovascular solutions. With a market capitalization..

Viatris Inc. (VTRS) Stock Analysis: Navigating a 7.31% Potential Upside in the Healthcare Sector

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, operates as a global pharmaceutical giant offering a diverse range of drug products. With a..

Corcept Therapeutics (CORT) Stock Analysis: 91% Upside Potential in the Biotechnology Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector with its promising pipeline and significant growth potential. Based in Redwood City, California, Corcept..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 67.59% Potential Upside Amidst Market Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, is navigating an interesting phase in its market journey. With a market cap of $10.55..

Johnson & Johnson (JNJ) Stock Analysis: Navigating the Healthcare Giant with a 2.90% Dividend Yield

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to capture investor interest with its robust portfolio and consistent dividend yield. With a..

Incyte Corporation (INCY) Stock Analysis: Exploring Growth Potential and Analyst Ratings in the Biotech Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is making waves with its innovative therapeutic solutions. Headquartered in Wilmington, Delaware, this biopharmaceutical giant..

Royalty Pharma plc (RPRX) Investor Outlook: Exploring a 19.15% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX), a premier player in the biotechnology sector, presents an intriguing opportunity for investors looking to capitalize on its unique business model..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating a Healthcare Giant with a Robust ROE

HCA Healthcare, Inc. (NYSE: HCA), a major player in the healthcare sector, commands the attention of investors with its impressive financial figures and strategic positioning. With..

BeOne Medicines Ltd. (ONC): Consensus Points to a 13% Upside Potential in Biotech Innovator

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of oncology treatments and a..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 15.81% Potential Upside in the Biotechnology Sector

Exelixis, Inc. (NASDAQ: EXEL) stands as a formidable player in the biotechnology sector, with a keen focus on oncology treatments. The company’s stock is currently priced..

Baxter International Inc. (BAX) Stock Analysis: Navigating a 19.63% Potential Upside in the Healthcare Sector

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is currently positioned at a pivotal moment for investors seeking opportunities in medical instruments and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds